Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Invasive Breast Cancer × cemiplimab × 1 year × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 33 Melanoma 13 Neoplasm Metastasis 11 Squamous Cell Carcinoma of Head and Neck 10 Skin Neoplasms 10 Lung Neoplasms 9 Recurrence 7 Neoplasms 7 Ovarian Neoplasms 6 Colorectal Neoplasms 6 Carcinoma, Squamous Cell 6 Carcinoma, Renal Cell 6 Adenocarcinoma 6 Urinary Bladder Neoplasms 5 Carcinoma, Basal Cell 5 Triple Negative Breast Neoplasms 4 Prostatic Neoplasms 4 Head and Neck Neoplasms 4 Glioblastoma 4 Colonic Neoplasms 4 Carcinoma 4 Breast Neoplasms 4 Uterine Cervical Neoplasms 3 Pancreatic Neoplasms 3 Mycosis Fungoides 3 Fallopian Tube Neoplasms 3 Cutaneous Squamous Cell Carcinoma 3 Carcinoma, Merkel Cell 3 Uveal Melanoma 2 Stomach Neoplasms 2

Interventions

liposomal doxorubicin 1 cemiplimab 1 Radiotherapy 1 Paclitaxel 1 Doxorubicin 1 Cyclophosphamide 1 Carboplatin 1 Albumin-Bound Paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04243616 2025-09-05

CemiHALT

Medical College of Wisconsin

Phase 2 Active not recruiting

Invasive Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡